vimarsana.com

Page 3 - சாம்பியன்கள் புற்றுநோயியல் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Agilent Technologies, Inc (NYSE:A) - The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Agilent Technologies, Inc (NYSE:A) - The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Champions Oncology, Inc : Champions Oncology Reports Record Quarterly Revenue of $10 8 Million

Champions Oncology, Inc.: Champions Oncology Reports Record Quarterly Revenue of $10.8 Million HACKENSACK, NJ / ACCESSWIRE / March 11, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global oncology technology solutions provider engaged in transforming drug discovery and development through data-driven research strategies and innovative pharmacology, biomarker and data platforms, today announced its financial results for the third fiscal quarter ended January 31, 2021. Third Quarter and Recent Highlights: Delivered record quarterly revenue of $10.8 million, an increase of 20% year over year Reported non-GAAP income from operations, excluding stock-based compensation, depreciation and amortization, of $1.3 million Expanded Lumin Bioinformatics proprietary SaaS platform with proteomic module integration Ronnie Morris, CEO of Champions, commented, We are pleased with our third quarter results and we continue to execute our long term strategy of investing in the developme

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.